Navigation path


TB PAN-NET: Pan-European network for study and clinical management of drug resistant tuberculosis.
Framework programme:
Project number:
EC contribution:
10,900,000 €
60 months
Large-scale integrating project
Starting date:
Project web site:

Keywords: Multi Drug-Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis, Molecular Diagnosis, Markers of Resistance.


As strains resistant to available anti-tuberculosis (TB) drugs have emerged, drug-resistant Mycobacterium tuberculosis strains have become a serious threat to TB control worldwide. Over 400 000 new cases of multidrug-resistant TB (MDR-TB) occur each year and the prevalence of MDR-TB cases in the world today may approach or exceed 1 million. Recent studies worldwide have revealed the presence not only of MDR-TB but also of what has come to be called extensively drug-resistant tuberculosis (XDR-TB). The global threat of XDR-TB has major implications for public health and particularly for HIV control because of the extreme vulnerability of these patients to TB, especially highly drug-resistant TB.

[+] Read More